Proteasomal Inhibition Potentiates Latent HIV Reactivation.

AIDS Research and Human Retroviruses
Daniele C Cary, B Matija Peterlin

Abstract

Despite the success of antiretroviral therapy (ART), ART fails to eradicate the virus and HIV cure has remained beyond the reach of current treatments. ART targets replicating virally infected but not latently infected cells, which have limited expression of factors important for proliferation and cellular activity, including positive transcription elongation factor b (P-TEFb) and nuclear factor κB (NF-κB). Levels of the cyclin T1 (CycT1) subunit of P-TEFb are low to absent in resting T cells, and treatment with proteasome inhibitors (PIs) increases CycT1 protein levels to those of proliferating T cells. In this study, the clinically approved PI bortezomib reactivated latent HIV in latently infected primary CD4+ T cells. Bortezomib not only increased levels of CycT1 but also activated NF-κB. Strikingly, as opposed to most currently researched latency reversing agents (LRAs), bortezomib did not require a second LRA to potently reactivate latent HIV. Effects of bortezomib on resting T cells and reactivation of HIV suggest a possible direction for future attempts to diminish the viral reservoir in HIV+ individuals.

References

Aug 11, 1991·Nucleic Acids Research·T M Antalis, D Godbolt
Nov 11, 1999·Genes & Development·J T WinstonJ W Harper
Nov 7, 2000·Current Opinion in Cell Biology·S V Ekholm, S I Reed
Jul 23, 2002·Journal of Virology·Yael D KorinJerome A Zack
Sep 17, 2004·Genes & Development·Matthew S Hayden, Sankar Ghosh
Jul 20, 2010·Current HIV Research·Moisés PérezEduardo Muñoz
Mar 3, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Shirin Arastu-KapurChristopher J Kirk
Jun 16, 2012·Molecular Biology International·Gillian M Schiralli Lester, Andrew J Henderson
Jul 28, 2012·Nature·Steven G Deeks
Jul 28, 2013·Cell Division·Katie R HagenHarold I Saavedra
Jul 12, 2014·Virology·Diego Pandeló JoséRenato Santana Aguiar
Mar 31, 2015·The Journal of Clinical Investigation·Gregory M LairdRobert F Siliciano
Jan 6, 2016·The Journal of Clinical Investigation·Daniele C CaryB Matija Peterlin
Jun 16, 2016·F1000Research·Daniele C Cary, B Matija Peterlin
Aug 25, 2016·The New England Journal of Medicine·Antonio PalumboUNKNOWN CASTOR Investigators
Dec 16, 2016·PloS One·Daniele C CaryB Matija Peterlin
Jan 25, 2017·Nature Reviews. Clinical Oncology·Elisabet E Manasanch, Robert Z Orlowski
Nov 1, 2017·Viruses·Tanja SeisslerJean-Christophe Paillart
Nov 6, 2018·PLoS Pathogens·Marie LeozKoh Fujinaga
Jun 30, 2019·International Journal of Molecular Sciences·Vivian K Rojas, In-Woo Park
Jun 29, 2016·Blood and Lymphatic Cancer : Targets and Therapy·Sara GrammaticoMaria Teresa Petrucci
Dec 12, 2019·Frontiers in Immunology·Michelle SeifJürgen Löffler
Jan 16, 2020·Viruses·Gerlinde VansantZeger Debyser

❮ Previous
Next ❯

Methods Mentioned

BETA
flow cytometry
electrophoresis
PMA
FACS

Software Mentioned

Image Studio
CellQuest Pro

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.